No abstract available
MeSH terms
- Aged
- Antibodies / blood*
- Biomarkers / blood
- ChAdOx1 nCoV-19 / administration & dosage
- ChAdOx1 nCoV-19 / adverse effects*
- Humans
- Immunoglobulins, Intravenous / administration & dosage
- Male
- Middle Aged
- Platelet Factor 4 / immunology*
- Pulmonary Embolism / chemically induced*
- Pulmonary Embolism / diagnosis
- Pulmonary Embolism / drug therapy
- Pulmonary Embolism / immunology
- Thrombocytopenia / chemically induced*
- Thrombocytopenia / diagnosis
- Thrombocytopenia / drug therapy
- Thrombocytopenia / immunology
- Treatment Outcome
- Vaccination / adverse effects*
- Venous Thromboembolism / chemically induced*
- Venous Thromboembolism / diagnosis
- Venous Thromboembolism / drug therapy
- Venous Thromboembolism / immunology
- Venous Thrombosis / chemically induced*
- Venous Thrombosis / diagnosis
- Venous Thrombosis / drug therapy
- Venous Thrombosis / immunology
Substances
- Antibodies
- Biomarkers
- Immunoglobulins, Intravenous
- PF4 protein, human
- Platelet Factor 4
- ChAdOx1 nCoV-19